基本信息
views: 382
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Einhorn's clinical interests include solid tumor oncology, specifically within the fields of genitourinary and lung cancers. His legacy will forever be linked with revolutionizing testicular cancer treatment. Prior to Dr. Einhorn's research in the area of platinum combination chemotherapy in patients with metastatic testicular cancer, the survival rate of the disease was approximately 10 percent. Now, due to Dr. Einhorn's monumental findings, the current survival rate for metastatic testicular cancer is at 80 percent.
Research Interests
Papers共 534 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JAMA oncologyno. 7 (2024): 912-922
JAMA ONCOLOGYno. 1 (2024): 132-134
EUROPEAN UROLOGYno. 4 (2024): 337-345
Cancerno. 18 (2024): 3115-3122
Journal of the National Cancer Instituteno. 3 (2024): 455-467
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 12092-12092
Urologic oncologyno. 9 (2023): 394.e1-394.e6
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e17027-e17027
Load More
Author Statistics
#Papers: 534
#Citation: 25809
H-Index: 84
G-Index: 150
Sociability: 7
Diversity: 3
Activity: 119
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn